STEM Animal Health completes first shipment of bluestem™ oral care products to PetSmart® Canada
31 août 2021 08h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that STEM Animal Health Inc., has shipped its first order of bluestem™ products to PetSmart® Canada, Canada largest...
Kane Biotech Announces Second Quarter 2021 Financial Results
26 août 2021 16h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its Second Quarter 2021 financial results. Second...
Kane Biotech to Release Second Quarter 2021 Financial Results on August 26 – Conference Call to Follow
19 août 2021 16h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Receives Decisions to Grant for Two European Patents Providing Broad Protection of coactiv+™ Technology for Wound Care, Skin Infections and Personal Care Formulations
29 juil. 2021 08h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, July 29, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that it has received two Decisions to Grant from the European Patent Office for patents covering its best-in-class...
Kane Biotech Expands its Wound Care and Surgical Portfolio with a coactiv+TM Antimicrobial Hydrogel
22 juil. 2021 08h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, July 22, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces plans to expand its wound care and surgical portfolio with an antimicrobial hydrogel based on its best-in-class...
Kane Biotech Announces Cancellation of Options and Issuance of Restricted Share Units
21 juil. 2021 16h30 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, July 21, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has cancelled 8,470,555 stock options of...
Kane Biotech announces two key milestones as DispersinB® wound care project advances towards human clinical trials
13 juil. 2021 08h00 HE
|
Kane Biotech Inc.
Development of a novel topical hydrogel formulation of DispersinB® with significantly improved stabilityNew manufacturing partnership with Dow Development Laboratories, LLC for clinical product...
Kane Biotech to meet investors at Whistler 2021 Capital Conference
29 juin 2021 10h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, June 29, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. will host investor meetings at the 10th Annual Whistler 2021 Capital Conference hosted by Capital Event Management the weekend...
Kane Biotech launches 2021 business update series
16 juin 2021 10h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, June 16, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), goes live today with the first of a 5-part “2021 business update”...
Kane Biotech Announces Adoption of Performance and Restricted Share Unit Plan and Amended and Restated Stock Option Plan
09 juin 2021 16h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, June 09, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announced that, at the annual and special meeting of...